Universe Pharmaceuticals INC SEC filings UPC
Universe Pharmaceuticals INC has 119 filings in SEC EDGAR's recent list, going back to Apr 24, 2020. Its latest annual report, Form 20-F, was filed on Jan 29, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Oct 6, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 9, 2026 | — |
| NT 20-F | Notification of late filing | Jan 27, 2025 | Sep 30, 2024 |
| EFFECT | Filing | Jun 7, 2024 | — |
| CORRESP | Letter to the SEC | Jun 5, 2024 | — |
| CORRESP | Letter to the SEC | May 14, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| NT 20-F | Notification of late filing | Jan 30, 2023 | Sep 30, 2022 |
| EFFECT | Filing | Nov 15, 2022 | — |
| EFFECT | Filing | Mar 22, 2021 | — |
| CERT | Filing | Mar 22, 2021 | — |
| CORRESP | Letter to the SEC | Mar 17, 2021 | — |
| CORRESP | Letter to the SEC | Mar 17, 2021 | — |
| 8-A12B | Form 8-a12b | Mar 17, 2021 | — |
| CORRESP | Letter to the SEC | Mar 10, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 2, 2021 | — |
| CORRESP | Letter to the SEC | Dec 2, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 19, 2020 | — |
| CORRESP | Letter to the SEC | Nov 17, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2020 | — |
| CORRESP | Letter to the SEC | Aug 17, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2020 | — |
| DRSLTR | Filing | Jun 12, 2020 | — |
| DRS/A | Filing | Jun 12, 2020 | — |
| UPLOAD | Letter from the SEC | May 20, 2020 | — |
| DRS | Filing | Apr 24, 2020 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- UPC (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- China
- Headquarters
- Ji'An, Jiangxi, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1809616
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.